Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. (Q43573537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

S John

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Jacobi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M P Schlaich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Schneider

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R E Schmieder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1351-1358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Improvement of coronary vasodilatation capacity through single LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Atherosclerosis and the two faces of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901128-7

7 January 2021

10.1016/S0735-1097(01)01128-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300446%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference